BlackRock, Inc. 13D and 13G filings for PTC Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | PTC Therapeutics, Inc. PTCT | BlackRock Inc. BLK | 6,274,384 8.000% | -1,394,487 (-18.18%) | Filing |
| 2024-01-08 4:35 pm Purchase | 2023-12-31 | 13G | PTC Therapeutics, Inc. PTCT | BlackRock Inc. BLK | 7,668,871 10.200% | 1,028,017 (+15.48%) | Filing |
| 2023-01-24 1:56 pm Purchase | 2022-12-31 | 13G | PTC Therapeutics, Inc. PTCT | BlackRock Inc. BLK | 6,640,854 9.200% | 250,913 (+3.93%) | Filing |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | PTC Therapeutics, Inc. PTCT | BlackRock Inc. BLK | 6,389,941 9.000% | 361,822 (+6.00%) | Filing |
| 2021-01-29 5:22 pm Purchase | 2020-12-31 | 13G | PTC Therapeutics, Inc. PTCT | BlackRock Inc. BLK | 6,028,119 8.800% | 1,113,526 (+22.66%) | Filing |